Suppr超能文献

口服甲氧苄啶-磺胺甲恶唑对儿童粪便菌群中肠杆菌科细菌的选择性抑制作用。

Selective inhibition of enterobacteriaceae in fecal flora of children by oral trimethoprim-sulfamethoxazole.

作者信息

Fujita K, Sakata H, Yoshioka H

出版信息

Pediatr Infect Dis. 1984 Nov-Dec;3(6):530-3. doi: 10.1097/00006454-198411000-00010.

Abstract

Fecal flora of nine pediatric inpatients who were receiving trimethoprim-sulfamethoxazole were studied by quantitative aerobic and anaerobic culture methods. During the course of trimethoprim-sulfamethoxazole, the number of Enterobacteriaceae decreased from 10(8-9) to 10(4-5) bacteria per g feces. The isolation rate and the number of Veillonella were also reduced. Other prominent aerobic and anaerobic flora, including Streptococcus, Bacteroidaceae and Bifidobacterium, were not affected. No overgrowth of Pseudomonas, Staphylococcus, Candida or Clostridium was noted. These results support the usefulness of oral trimethoprim-sulfamethoxazole for the prophylaxis of bacterial infection in the compromised host.

摘要

采用定量需氧和厌氧培养方法,对9名正在接受甲氧苄啶 - 磺胺甲恶唑治疗的儿科住院患者的粪便菌群进行了研究。在接受甲氧苄啶 - 磺胺甲恶唑治疗期间,每克粪便中肠杆菌科细菌数量从10(8 - 9) 降至10(4 - 5)。韦荣球菌的分离率和数量也有所降低。其他主要的需氧和厌氧菌群,包括链球菌、拟杆菌科和双歧杆菌,未受影响。未观察到假单胞菌、葡萄球菌、念珠菌或梭菌的过度生长。这些结果支持口服甲氧苄啶 - 磺胺甲恶唑对预防免疫功能低下宿主的细菌感染有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验